PROCEPT BioRobotics Corporation Common Stock

PRCTNASDAQUSD
21.15 USD
0.10 (0.47%)🟢LIVE (AS OF 10:37 AM EDT)
🟢Market: OPEN

PRCT is currently priced at $21.15. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, PRCT trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 24, 2026.

Open?$21.25
High?$21.52
Low?$20.93
Prev. Close?$21.25
Volume?89.8K
Avg. Volume?1.6M
VWAP?$21.23
Rel. Volume?0.05x
Bid / Ask
Bid?$18.06 × 200
Ask?$21.47 × 100
Spread?$3.41
Midpoint?$19.77
Valuation & Ratios
Market Cap?1.2B
Shares Out?57.3M
Float?52.9M
Float %?92.9%
P/E Ratio?N/A
P/B Ratio?3.58
EPS?-$1.92
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Employees
888
Market Cap
1.2B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2021-09-15
Address
150 BAYTECH DRIVE
SAN JOSE, CA 95134
Phone: (650) 232-9832
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
92
Momentum?
40
Short Sent.?
45
Piotroski F-Score?1/9Weak
Altman Z-Score?4.01Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.41%High
Short Interest?7.1M
Days to Cover?5.1
Free Float52.9M
Avg Daily Volume1.4M
Settlement Date2026-07-31
Financial Health
Current Ratio?6.55Strong
Quick Ratio?5.35Strong
Cash Ratio?3.55Strong
Debt/Equity?0.15Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A
P/B?
Peers
100
S&P
48
3.58FAIR
P/S?
Peers
100
S&P
42
3.61FAIR
P/FCF?
N/A
EV/EBITDA?
S&P
97
-9.7CHEAP
EV/Sales?
Peers
100
S&P
59
3.09FAIR
Returns & Efficiency
ROE?
S&P
6
-32.3%WEAK
ROA?
S&P
3
-22.9%WEAK
Cash Flow & Enterprise
FCF?$-84925000
Enterprise Value?$1.0B
Fundamentals ratios updated end of day